https://www.insilico.com | Hong Kong | 2014 | $402M
Insilico Medicine is a biotechnology company in Hong Kong that develops AI solutions for drug discovery. They use GANs and reinforcement learning to identify protein targets and generate molecular structures. The company collaborates with top pharmaceutical companies globally and has diverse global investors. Founded in 2014, it is led by CEO Alex Zhavoronkov, PhD, and a team of experienced executives and scientists.
